Trial Profile
Swdeish Exelon Titration study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jun 2011
Price :
$35
*
At a glance
- Drugs Rivastigmine (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 23 Jun 2011 New trial record